These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 35293987)
1. Incidence of an Insulin-Requiring Hyperglycemic Syndrome in SARS-CoV-2-Infected Young Individuals: Is It Type 1 Diabetes? Pietropaolo M; Hotez P; Giannoukakis N Diabetes; 2022 Dec; 71(12):2656-2663. PubMed ID: 35293987 [TBL] [Abstract][Full Text] [Related]
2. Examining the associations between COVID-19 infection and pediatric type 1 diabetes. Bombaci B; Passanisi S; Sorrenti L; Salzano G; Lombardo F Expert Rev Clin Immunol; 2023 May; 19(5):489-497. PubMed ID: 36888906 [TBL] [Abstract][Full Text] [Related]
3. Increased frequency of severe diabetic ketoacidosis at type 1 diabetes onset among children during COVID-19 pandemic lockdown: an observational cohort study. Dżygało K; Nowaczyk J; Szwilling A; Kowalska A Pediatr Endocrinol Diabetes Metab; 2020; 26(4):167-175. PubMed ID: 33554490 [TBL] [Abstract][Full Text] [Related]
4. Comment on Pietropaolo et al. Incidence of an Insulin-Requiring Hyperglycemic Syndrome in SARS-CoV-2-Infected Young Individuals: Is It Type 1 Diabetes? Diabetes 2022;71:2656-2663. Hsu CK; Lai CC Diabetes; 2022 Dec; 71(12):e18. PubMed ID: 36409785 [No Abstract] [Full Text] [Related]
5. Response to Comment on Pietropaolo et al. Incidence of an Insulin-Requiring Hyperglycemic Syndrome in SARS-CoV-2- Infected Young Individuals: Is It Type 1 Diabetes? Diabetes 2022;71:2656-2663. Pietropaolo M; Hotez P; Giannoukakis N Diabetes; 2022 Dec; 71(12):e19. PubMed ID: 36409787 [No Abstract] [Full Text] [Related]
6. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2. Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG mBio; 2020 Sep; 11(5):. PubMed ID: 32913009 [TBL] [Abstract][Full Text] [Related]
7. Analysis of ACE2 genetic variants in 131 Italian SARS-CoV-2-positive patients. Novelli A; Biancolella M; Borgiani P; Cocciadiferro D; Colona VL; D'Apice MR; Rogliani P; Zaffina S; Leonardis F; Campana A; Raponi M; Andreoni M; Grelli S; Novelli G Hum Genomics; 2020 Sep; 14(1):29. PubMed ID: 32917283 [TBL] [Abstract][Full Text] [Related]
8. School and pre-school children with type 1 diabetes during Covid-19 quarantine: The synergic effect of parental care and technology. Schiaffini R; Barbetti F; Rapini N; Inzaghi E; Deodati A; Patera IP; Matteoli MC; Ciampalini P; Carducci C; Lorubbio A; Schiaffini G; Cianfarani S Diabetes Res Clin Pract; 2020 Aug; 166():108302. PubMed ID: 32623034 [TBL] [Abstract][Full Text] [Related]
9. No effects of COVID-19 on the development of type 1 diabetes autoimmunity and no evidence of an increased frequency of SARS-CoV-2 antibodies in newly diagnosed type 1 diabetes patients relative to healthy subjects. Tiberti C; Nenna R; Tromba V; Filardi T; Petrarca L; Silvestri F; Fassino V; Montuori M; Mancino E; Lenzi A; Midulla F; Costantino F; Morano S Acta Diabetol; 2023 Oct; 60(10):1301-1307. PubMed ID: 37171699 [TBL] [Abstract][Full Text] [Related]
10. New-onset type 1 diabetes and severe acute respiratory syndrome coronavirus 2 infection. Anindya R; Rutter GA; Meur G Immunol Cell Biol; 2023 Mar; 101(3):191-203. PubMed ID: 36529987 [TBL] [Abstract][Full Text] [Related]
11. Diagnosis of type 1 diabetes during the SARS-CoV-2 pandemic: Does lockdown affect the incidence and clinical status of patients? Zubkiewicz-Kucharska A; Seifert M; Stępkowski M; Noczyńska A Adv Clin Exp Med; 2021 Feb; 30(2):127-134. PubMed ID: 33599404 [TBL] [Abstract][Full Text] [Related]
12. Incidences of newly diagnosed childhood diabetes and onset severity: a multicenter regional study in Thailand over two decades and during the COVID-19 pandemic. Sinthuprasith P; Wejaphikul K; Puttawong D; Tang-Ngam H; Sanrattana N; Unachak K; Dejkhamron P J Pediatr Endocrinol Metab; 2024 Jun; 37(6):487-496. PubMed ID: 38615333 [TBL] [Abstract][Full Text] [Related]
13. DKA and new-onset type 1 diabetes in Brazilian children and adolescents during the COVID-19 pandemic. Luciano TM; Halah MP; Sarti MTA; Floriano VG; da Fonseca BAL; Del Roio Liberatore R; Antonini SR Arch Endocrinol Metab; 2022 Mar; 66(1):88-91. PubMed ID: 35029857 [TBL] [Abstract][Full Text] [Related]
14. COVID-19 as a Trigger for Type 1 Diabetes. Wang Y; Guo H; Wang G; Zhai J; Du B J Clin Endocrinol Metab; 2023 Aug; 108(9):2176-2183. PubMed ID: 36950864 [TBL] [Abstract][Full Text] [Related]
15. Newly-onset Autoimmune Diabetes Mellitus Triggered by COVID 19 Infection: A Case-based Review. Akkuş G Endocr Metab Immune Disord Drug Targets; 2023; 23(7):887-893. PubMed ID: 36200218 [TBL] [Abstract][Full Text] [Related]
16. Outcomes in Patients with COVID-19 Infection Taking ACEI/ARB. Rico-Mesa JS; White A; Anderson AS Curr Cardiol Rep; 2020 Apr; 22(5):31. PubMed ID: 32291526 [TBL] [Abstract][Full Text] [Related]
17. COVID-19 in Newborns and Infants-Low Risk of Severe Disease: Silver Lining or Dark Cloud? Rawat M; Chandrasekharan P; Hicar MD; Lakshminrusimha S Am J Perinatol; 2020 Jun; 37(8):845-849. PubMed ID: 32380565 [TBL] [Abstract][Full Text] [Related]
18. Expression of SARS-CoV-2 receptor "ACE2" in human pancreatic β cells: to be or not to be! El-Huneidi W; Hamad M; Taneera J Islets; 2021 Sep; 13(5-6):106-114. PubMed ID: 34304698 [TBL] [Abstract][Full Text] [Related]
19. Type 1 diabetes recurrence after SARS-CoV-2 infection in a subject with pancreas transplantation. Popolla V; Rizzi A; Tartaglione L; Pontecorvi A; Pitocco D Endocrinol Diabetes Metab; 2023 Jan; 6(1):e364. PubMed ID: 36307982 [TBL] [Abstract][Full Text] [Related]
20. Hyperglycemia, hydroxychloroquine, and the COVID-19 pandemic. Brufsky A J Med Virol; 2020 Jul; 92(7):770-775. PubMed ID: 32293710 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]